Company profile

Switch Therapeutics

Developing the next generation of RNAi drugs

Industry
Biotechnology Research
Employees
28
Headquarters
San Francisco, California
Founded
2020
LinkedIn followers
3,506
Office locations
1

Switch Therapeutics company summary

Switch Therapeutics is a company in the Biotechnology Research industry, headquartered in San Francisco, California, founded in 2020. On LinkedIn the company has around 28 employees and 3,506 followers.

What technology does Switch Therapeutics use?

No technologies detected yet. Warmrank rechecks company websites on a rolling basis.

About Switch Therapeutics

Switch Therapeutics is an emerging preclinical stage biotechnology company pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science with the goal of treating a range of diseases – affecting the central nervous system and systemic indications – with significant unmet needs. Switch’s novel gene knockdown approach is based on technology developed by renowned researchers in the field of RNA from Caltech, Harvard and City of Hope. Based on the scientific discovery of Switch’s co-founders, the company has developed a novel proprietary platform known as CASi (Conditionally Activated siRNAs) that combines advantageous properties of both single and double-stranded RNAs in a single molecule, allowing for cell selective RNAi activity. To date, Switch has raised $52M in funding through Series A, and the company’s South San Francisco based team has continued to grow as its research has advanced.

Where is Switch Therapeutics located?

Switch Therapeutics lists 1 location.

San Francisco, California, USHQ

Compare companies similar to Switch Therapeutics

More companies in Biotechnology Research.

CompanyIndustryEmployeesFoundedHeadquarters
Switch Therapeutics
switchthera.com
Biotechnology Research282020San Francisco, California
Thermo Fisher Scientific
thermofisher.com
Biotechnology Research100,779-Waltham, MA
Amgen
amgen.com
Biotechnology Research41,0281980Thousand Oaks, CA
Biogen
biogen.com
Biotechnology Research7,742-Cambridge, MA
Biocon
biocon.com
Biotechnology Research11,902-Bangalore, Karnataka
Biotechnology Research28,679-Bethesda, MD
Genentech
gene.com
Biotechnology Research18,2961976South San Francisco, California
Eurofins
eurofins.com
Biotechnology Research24,928-Luxembourg, Luxembourg
Gilead Sciences
gilead.com
Biotechnology Research14,743-Foster City, CA
Syneos Health
syneoshealth.com
Biotechnology Research23,772-Morrisville, NC
Moderna
modernatx.com
Biotechnology Research6,2382010Cambridge, Massachusetts

Frequently asked questions about Switch Therapeutics

What does Switch Therapeutics do?

Switch Therapeutics is an emerging preclinical stage biotechnology company pioneering a new type of medicine that integrates nucleic acid nanotechnology and RNA interference (RNAi) science with the goal of treating a range of diseases – affecting the central nervous system and systemic indications – with significant unmet needs. Switch’s novel gene knockdown approach is based on technology developed by renowned researchers in the field of RNA from Caltech, Harvard and City of Hope. Based on the scientific discovery of Switch’s co-founders, the company has developed a novel proprietary platform known as CASi (Conditionally Activated siRNAs) that combines advantageous properties of both single and double-stranded RNAs in a single molecule, allowing for cell selective RNAi activity. To date, Switch has raised $52M in funding through Series A, and the company’s South San Francisco based team has continued to grow as its research has advanced.

How many employees does Switch Therapeutics have?

Switch Therapeutics has around 28 employees on LinkedIn.

Where is Switch Therapeutics headquartered?

Switch Therapeutics is headquartered in San Francisco, California.

When was Switch Therapeutics founded?

Switch Therapeutics was founded in 2020.

Build a lead list from companies like Switch Therapeutics

Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.